Variable | Total population | P. spp. PCR− (n = 414) | P. spp. PCR+ (n = 70)a | P value | Pf PCR+ (n = 42)b | Pv PCR+ (n = 25)b | P value |
---|---|---|---|---|---|---|---|
Age (years), n (%) | |||||||
 ≤5 | 131 (27.1%) | 112 (27.1%) | 19 (27.1%) | 0.153 | 11 (26.2%) | 7 (28.0%) | 0.906 |
 6–14 | 31 (6.4%) | 26 (6.3%) | 5 (7.1%) | 2 (4.8%) | 2 (8%) | ||
 15–24 | 91 (18.8%) | 78 (18.8%) | 13 (18.6%) | 9 (21.4%) | 4 (16%) | ||
 25–64 | 198 (40.9) | 171 (41.3%) | 27 (38.6%) | 17 (40.5%) | 9 (36%) | ||
 ≥65 | 33 (6.8%) | 27 (6.5%) | 6 (8.6%) | 3 (7.1%) | 3 (12%) | ||
 Median [IQR] | 24 [4–40] | 23 [4–43] | 24 [4–39] | 0.732 | 23 [4–42] | 21 [3–37] | 0.721 |
Sex, n (%) | |||||||
 Male | 191 (39.5%) | 151 (36.5%) | 40 (57.1%) | 0.001 | 24 (57.1%) | 14 (56%) | 1.000 |
 Female | 293 (60.5%) | 263 (63.5%) | 30 (42.9%) | 18 (42.9%) | 11 (44%) | ||
Provenance, n (%) | |||||||
 Urban | 316 (65.3%) | 264 (63.8%) | 52 (74.3%) | 0.103 | 30 (71.4%) | 19 (76%) | 0.780 |
 Rural | 168 (34.7%) | 150 (36.2%) | 18 (25.7%) | 12 (28.6%) | 6 (24%) | ||
Ethnicity, n (%) | |||||||
 Bamiléké | 429 (89%) | 363 (88%) | 66 (94%) | 0.151 | 40 (95%) | 24 (96%) | 1.000 |
 Others | 55 (11%) | 51 (12%) | 4 (6%) | 2 (5%) | 1 (4%) | ||
Co-morbidity, n (%) | |||||||
 No | 448 (92.6%) | 383 (92.5%) | 65 (92.9%) | 1.000 | 38 (90.5%) | 24 (96%) | 0.643 |
 Yes | 36 (7.4%) | 31 (7.5%) | 5 (7.1%) | 4 (9.5%) | 1 (4) | ||
 Diabetes | 8 (1.6%) | 8 (1.9%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
 AHT | 19 (3.9%) | 15 (3.7%) | 4 (5.7%) | 3 (7.1%) | 1 (4%) | ||
 AHT + diabetes | 5 (1.1%) | 5 (1.2%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
 AHT + bronchial asthma | 1 (0.2%) | 1 (0.2%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
 Bronchial asthma | 1 (0.2%) | 1 (0.2%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
 HIV infection | 1 (0.2%) | 1 (0.2%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
 HCV infection | 1 (0.2%) | 0 (0%) | 1 (1.4%) | 1 (2.4%) | 0 (0%) | ||
Pregnancy, n (%)c | |||||||
 Yes | 17 (5.8%) | 15 (5.7%) | 2 (6.7%) | 0.688 | 0 (0%) | 2 (18.2%) | 0.135 |
 No | 276 (94.2%) | 248 (94.3%) | 28 (93.3%) | 18 (100%) | 9 (81.8%) | ||
Previous anti-malarial self-medication, n (%)d | |||||||
 Yes | 198 (40.9%) | 168 (40.6%) | 30 (42.9%) | 0.952 | 18 (42.9%) | 11 (44%) | 0.952 |
 No | 286 (59.1%) | 246 (59.4%) | 40 (57.1%) | 24 (57.1%) | 14 (56%) | ||
Diagnostic delay (days) | |||||||
 Median [range] | 3 [2–7] | 3 [1–6] | 3 [2–7] | 0.144 | 3.5 [2–7] | 3 [2–7] | 0.707 |